Isocitrate dehydrogenase mutation hot spots in acute lymphoblastic leukemia and oral cancer
Isocitrate dehydrogenase (IDH) encodes a nicotinamide adenine dinucleotide phosphate+-dependent enzyme for oxidative decarboxylation of isocitrate and has an essential role in the tricarboxylic acid cycle. Mutations of IDH1 and IDH2 have been identified in patients with glioma, leukemia, and other c...
Main Authors: | Jen-Yang Tang, Chun-Chi Chang, Pei-Chin Lin, Jan-Gowth Chang |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2012-03-01
|
Series: | Kaohsiung Journal of Medical Sciences |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S1607551X11002464 |
Similar Items
-
Investigation of Isocitrate Dehydrogenase 1 and 2 Mutations in Acute Leukemia Patients in Saudi Arabia
by: Heba Alkhatabi, et al.
Published: (2021-12-01) -
Isocitrate dehydrogenase 1 mutation in cholangiocarcinoma impairs tumor progression by sensitizing cells to ferroptosis
by: Su Li, et al.
Published: (2022-05-01) -
Molecular alterations of isocitrate dehydrogenase 1 and 2 (<it>IDH1 </it>and <it>IDH2</it>) metabolic genes and additional genetic mutations in newly diagnosed acute myeloid leukemia patients
by: Chotirat Sadudee, et al.
Published: (2012-03-01) -
Isocitrate Dehydrogenase Mutations in Glioma: Genetics, Biochemistry, and Clinical Indications
by: Yang Liu, et al.
Published: (2020-08-01) -
Somatic mutations of isocitrate dehydrogenases 1 and 2 are prognostic and follow-up markers in patients with acute myeloid leukaemia with normal karyotype
by: Virijevic Marijana, et al.
Published: (2016-12-01)